Gracell Biotechnologies Inc. Quarterly Liabilities, Current in USD from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: CNY and USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Gracell Biotechnologies Inc. quarterly Liabilities, Current history and growth rate from Q4 2020 to Q2 2023.
Gracell Biotechnologies Inc. Liabilities, Current for the quarter ending June 30, 2023 was $26.7M, a 17.5% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$26.7M	-$5.69M	-17.5%	Jun 30, 2023	6-K	2023-08-14
Q4 2022	$32M	+$7.65M	+31.4%	Dec 31, 2022	20-F	2023-04-25
Q2 2022	$32.4M			Jun 30, 2022	6-K	2022-08-15
Q4 2021	$24.3M	+$10M	+70.1%	Dec 31, 2021	20-F	2022-04-22
Q4 2020	$14.3M			Dec 31, 2020	20-F	2021-04-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.